TY - JOUR
T1 - The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer
Y1 - 2024
PY - 2024
DA - 2024
N1 - doi:2023.36214
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 58
EP - 66
VL - 8
IS - 1
SN - 
M3 - doi:2023.36214
UR - https://dx.doi.org/10.14744/ejmi.2023.36214
Y2 - 2024
ER -